Carissa Chu

Excited to see our paper in print @EUplatinum: europeanurology.com/article/S0302-… Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

Palliative care is about more than end-of-life - it’s about quality of life. Drs. Pauline Filippou & Ashwin Kotwal join @GMBadalato & @lindsayahampson to discuss why palliative care belongs in urology & how to integrate it into everyday practice #URO249 open.spotify.com/episode/0nes3s…

🚨New in @EUPlatinum! 📌 PSMA PET for Prostate Cancer Diagnosis & Staging by @elio_mazzone et al 🧠 This comprehensive meta-analysis confirms the high diagnostic value of PSMA PET—especially when combined with MRI—but reminds us it’s not enough to skip biopsy or lymph node…

Congratulations to @arihakimi who was chosen unanimously by the class of 2025 Urologic Oncology Fellows as Teacher of the Year. Well deserved! @MTDawidek @MariaPereMD @sunny_nal @therealUroJET @UroMuneeb

Congrats to Kevin Shee for matching into the UCSF UroOnc SUO fellowship program! @KShee11 #UroOnc #SUO #SUOMatch

New review on urothelial carcinoma highlights therapeutic & diagnostic approaches in the perioperative setting, emphasizing patient‐centered & individualized care. acsjournals.onlinelibrary.wiley.com/doi/full/10.33… @WesleyYipMD @SalvadorjcMD @KothariAnjaney @domesypantsx3 @AnneSchuckmanMD @DrRosenbergMSK

Thanks for welcoming the second generation Feng to ASCO! What’s your #ASCO25 happy dance? @DrChoueiri @nlinmd @DrKarenKnudsen @DrPaulNguyen @APDicker @EdwinPosadasMD @DrKatePedersen @JoshLangMD @PamelaKunzMD @fumikochino

Now published in @JUrology by @UrologyMSK Sherri Donat, @eugene_pietzak, @EKChaMD, @bca_md, @bbmdmsk, @alvincgoh et al: Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy With Intracorporeal Ileal Conduit doi.org/10.1097/JU.000…

12/12 Summary, men >70yo absolutely can benefit from personalized screening. A) Comorbidities/life expectancy should be estimated B) PSA should be used to guide screening based on A C) MRI should be used based on A and B D) Biopsy should be used based on A-C -Observation or PSA…

Excited to share our latest work, now out in European Urology! We followed >166k prostate cancer survivors (1999–2019) using SEER-Medicare. RP+EBRT had the highest risk of urinary adverse events. EBRT surpassed RP at 10 yrs (with BT) & 14 yrs (alone). authors.elsevier.com/sd/article/S03…

UCSF BCAN community really showed up for our walk this year, babies and 4 legged friends alike, to support our patients with bladder CA and raising $40k for research. No one walks alone 🧡@bcan_chisolm @UCSFCancer @UCSFUrology @SimaPorten @jonchou05 @koshkin85 @SamWashUro

Revolutionizing #ProstateCancer care! @CChuMD @UCSFUrology presents on the crucial role of PSMA PET in surgical planning & post-op management, highlighting preoperative staging, intraoperative guidance with PSMA-conjugated fluorophore IS-002, and biochemical recurrence…

My favorite GR - graduating chief residents discuss their projects from their research year

1/2 POTOMAC is the last of the 15 PD(L)1 monotherapy IO R3 trials over 10yrs & >8000 pts in bladder cancer. The summary shows 1)clearer activity in earlier disease 2)the biomaker failing 3)PD-L1 & PD1 targeting having equal success 4)An unidentified subset respond in all settings

A mentee’s success is 100x better than your own. Congratulations @IlanoArielle on her Dean’s Prize for work with @UCSFUrology, as well as upcoming graduation from @UCSFMedicine, and match with @UCSFAnesthesia. 🌟🌟 @ben_breyer @AShindelGHI @lindsayahampson @pcarroll_